Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07398651
NA
Apremilast and Adalimumab in Psoriatic Arthritis Patients
Sponsor: Tanta University
View on ClinicalTrials.gov
Summary
The aim of this work is to compare the efficacy of Apremilast combined with Methotrexate versus Adalimumab combined with Methotrexate
Official title: Comparative Study Between Apremilast and Adalimumab in Psoriatic Arthritis Patients
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-12-30
Completion Date
2026-12-30
Last Updated
2026-02-10
Healthy Volunteers
No
Interventions
DRUG
Adalimumab
PsA patients who will receive Adalimumab with methotrexate therapy for 3 months
DRUG
Apremilast
PsA patients who will receive Apremilast with methotrexate therapy for 3 months
Locations (1)
Tanta University
Tanta, Egypt